Lung cancer in Brazil-Reference-Cited by-同舟云学术

Lung cancer in Brazil

Published:2018-02 Issue:1 Volume:44 Page:55-64
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:
Short-container-title:J. bras. pneumol.

Author:

Araujo Luiz Henrique¹^ORCID,Baldotto Clarissa¹^ORCID,Castro Jr Gilberto de²^ORCID,Katz Artur³^ORCID,Ferreira Carlos Gil⁴^ORCID,Mathias Clarissa⁵^ORCID,Mascarenhas Eldsamira⁵^ORCID,Lopes Gilberto de Lima⁶^ORCID,Carvalho Heloisa⁷^ORCID,Tabacof Jaques⁸,Martínez-Mesa Jeovany⁹^ORCID,Viana Luciano de Souza¹⁰^ORCID,Cruz Marcelo de Souza¹¹^ORCID,Zukin Mauro¹^ORCID,Marchi Pedro De¹⁰^ORCID,Terra Ricardo Mingarini¹²^ORCID,Ribeiro Ronaldo Albuquerque¹³,Lima Vladmir Cláudio Cordeiro de¹⁴^ORCID,Werutsky Gustavo¹⁵^ORCID,Barrios Carlos Henrique¹⁶^ORCID

Affiliation:

1. Instituto Nacional de Câncer José Alencar Gomes da Silva, Brasil; Instituto COI de Educação e Pesquisa, Brasil

2. Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Brasil; Hospital Sírio-Libanês, Brazil

3. Hospital Sírio-Libanês, Brazil

4. Instituto D’Or de Pesquisa e Ensino, Brasil; Fundação do Câncer, Brasil

5. Núcleo de Oncologia da Bahia, Brasil

6. Centro Paulista de Oncologia, Brasil; HCor Onco, Brasil

7. Hospital Sírio-Libanês, Brazil; Universidade de São Paulo, Brazil

8. Centro Paulista de Oncologia, Brasil

9. Faculdade Meridional IMED, Brasil

10. Hospital de Câncer de Barretos, Brazil

11. Centro Oncológico Antônio Ermírio de Moraes, Brasil

12. Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Brasil

13. Instituto do Câncer do Ceará, Brazil

14. A.C. Camargo Cancer Center, Brazil

15. Latin American Cooperative Oncology Group, Brasil

16. Pontifícia Universidade Católica do Rio Grande do Sul, Brazil

Abstract

ABSTRACT Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.

Publisher

FapUNIFESP (SciELO)

Subject

Pulmonary and Respiratory Medicine

Link

http://www.scielo.br/pdf/jbpneu/v44n1/1806-3713-jbpneu-44-01-00055.pdf

Reference77 articles.

1. International Agency for Research on Cancer (IARC),2016

2. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2016

3. Estimativa 2016: Incidência de Câncer no Brasil,2015

4. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2);Allemani C;Lancet,2015

5. Estatísticas do Câncer: Mortalidade

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors for the treatment of non-small cell lung cancer: The regulatory journey in Brazil;Critical Reviews in Oncology/Hematology;2023-12

2. Nutraceuticals and Nanonutraceuticals Formulation for Chronic Disease – Cancer;Handbook of Nutraceuticals;2023-11-14

3. The journey of stage III and IV non-small cell lung cancer patients in the Brazilian private healthcare system: a retrospective study;Frontiers in Oncology;2023-10-18

4. Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer;Journal of Cancer Research and Clinical Oncology;2023-10-16

5. EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing;JCO Global Oncology;2023-09